Real-life implementation of prenatal cell-free DNA screening with in vitro fetal enrichment virtually eliminates the need for redraws and improves performance: A cohort study
Prenatal cfDNA screening with in vitro fetal enrichment enhances accessibility and reliability of prenatal screening, nearly eliminating test failures and providing timely results for all samples, regardless of maternal BMI.
Authors
- Sylvie Langlois (ORCID: https://orcid.org/0000-0001-9301-3625)
- Sylvie Giroux (ORCID: https://orcid.org/0000-0001-7515-5267)
- André Caron (ORCID: https://orcid.org/0000-0003-3648-1179)
- François Rousseau (ORCID: https://orcid.org/0000-0002-4504-5507)
- Julie Jeukens (ORCID: https://orcid.org/0000-0001-8896-4338)
- Yves Giguère (ORCID: https://orcid.org/0000-0002-8655-1609)
- Emmanuel Bujold (ORCID: https://orcid.org/0000-0002-6936-4369)
- François Audibert (ORCID: https://orcid.org/0000-0002-2697-3826)
- Jean‐Claude Forest (ORCID: https://orcid.org/0000-0002-5910-5822)
- Seyedeh Saideh Daryabari (ORCID: https://orcid.org/0000-0003-1951-0847)
Institutions
- University of British Columbia (CA)
- Centre Hospitalier Universitaire Sainte-Justine (CA)
- Hôpital Saint-François d'Assise (CA)
- Centre hospitalier de l'Université Laval (CA)
- Université Laval (CA)
Publication Details
- Journal
- Genetics in Medicine Open
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1016/j.gimo.2025.103458
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00